• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[新型熊去氧胆酸衍生物在实验性酒精性脂肪性肝炎中的预防性给药]

[Preventive administration of new UDCA derivatives in experimental alcoholic steatohepatitis].

作者信息

Belonovskaia E B, Naruta E E, Lukivskaia O Ia, Abakumov V Z, Buko V U

出版信息

Eksp Klin Farmakol. 2013;76(1):25-9.

PMID:23461012
Abstract

We have studied the prophylactic effect of new derivatives of ursodeoxycholic acid (UDCA), including UDCA-N-acetylcysteine, UDCA-L-acetylcysteine, and nor-UDCA (in doses equivalent to 40 mg/kg of UDCA) on the development of experimental alcoholic steatohepatitis induced by the Lieber-DeCarli liquid ethanol-containing diet. Results demonstrated that most of the investigated compounds produced a hepatoprotective effect, improving biochemical tests and liver morphology, as manifested by decreasing steatosis intensity, activity of alkaline phosphatase and gamma-glutamyltranspeptidase, triglyceride level in blood serum and liver, and TNF alpha content. However, nor-UDCA was most effective as compared to UDCA in preventing the accumulation of triglycerides in the liver.

摘要

我们研究了熊去氧胆酸(UDCA)的新衍生物,包括UDCA-N-乙酰半胱氨酸、UDCA-L-乙酰半胱氨酸和去氢熊去氧胆酸(剂量相当于40mg/kg的UDCA)对由含乙醇的Lieber-DeCarli液体饮食诱导的实验性酒精性脂肪性肝炎发展的预防作用。结果表明,大多数研究的化合物产生了肝保护作用,改善了生化检测和肝脏形态,表现为脂肪变性强度降低、碱性磷酸酶和γ-谷氨酰转肽酶活性降低、血清和肝脏中的甘油三酯水平降低以及TNFα含量降低。然而,与UDCA相比,去氢熊去氧胆酸在预防肝脏中甘油三酯积累方面最有效。

相似文献

1
[Preventive administration of new UDCA derivatives in experimental alcoholic steatohepatitis].[新型熊去氧胆酸衍生物在实验性酒精性脂肪性肝炎中的预防性给药]
Eksp Klin Farmakol. 2013;76(1):25-9.
2
Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis.熊去氧胆酸在实验性酒精性脂肪性肝炎中肝脏保护作用的抗氧化机制
Adv Med Sci. 2006;51:54-9.
3
Effect of ursodeoxycholic acid on prostaglandin metabolism and microsomal membranes in alcoholic fatty liver.
Alcohol. 2001 Oct;25(2):99-105. doi: 10.1016/s0741-8329(01)00171-9.
4
Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.ω-3多不饱和脂肪酸和熊去氧胆酸在减轻小鼠饮食诱导的非酒精性脂肪性肝炎方面具有相加作用。
Exp Mol Med. 2014 Dec 19;46(12):e127. doi: 10.1038/emm.2014.90.
5
Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.熊去氧胆酸、白藜芦醇和N-乙酰半胱氨酸对大鼠非酒精性脂肪性肝病的保护作用
Pharm Biol. 2016 Jul;54(7):1198-208. doi: 10.3109/13880209.2015.1060247. Epub 2015 Jul 1.
6
Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.熊去氧胆酸通过抑制肝内肿瘤坏死因子-α和巨噬细胞炎性蛋白-2的产生来保护刀豆蛋白A诱导的小鼠肝损伤。
Eur J Pharmacol. 2008 Jan 6;578(1):57-64. doi: 10.1016/j.ejphar.2007.08.031. Epub 2007 Sep 4.
7
Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.熊去氧胆酰溶血磷脂酰乙醇胺改善非酒精性脂肪性肝病异常血脂谱。
Eur J Clin Invest. 2015 Sep;45(9):925-31. doi: 10.1111/eci.12486. Epub 2015 Jul 14.
8
Treatment of NASH with ursodeoxycholic acid: pro.熊去氧胆酸治疗非酒精性脂肪性肝炎:赞成。
Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S41-5. doi: 10.1016/S2210-7401(12)70020-7.
9
Ursodeoxycholate alleviates alcoholic fatty liver damage in rats.
Alcohol Clin Exp Res. 1998 Oct;22(7):1538-43.
10
Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
Transpl Int. 2005 May;17(12):804-9. doi: 10.1007/s00147-004-0703-x. Epub 2005 Apr 7.

引用本文的文献

1
Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review.熊去氧胆酸治疗非胆汁淤积性肝病的系统评价
J Clin Transl Hepatol. 2016 Sep 28;4(3):192-205. doi: 10.14218/JCTH.2016.00023. Epub 2016 Aug 2.